pain Less Painful Childbirth Associated With Rare Variant in Ion Channel Gene First-time mothers who did not request pain relief during labor were more likely to carry a rare variant in a potassium channel-coding gene. The DNA Company Rebrands as My Next Health Following Acquisition Functional genomics firm The DNA Company acquired digital therapeutics app My Pain Sensei, giving it an AI development platform and a Health Canada medical device license. NIH Announces Upcoming Genomic Medicine Studies The trials are part of the second phase of the Implementing Genomics in Practice program, which is slated to receive $42 million in funding over 5 years. Chronic Back Pain Linked to Three Loci in New Genome-Wide Analysis These three loci implicated skeletal and spinal cord development-linked pathways in chronic back pain. Opium Poppy Genome Provides Look at Painkiller Compound Evolution After a series of duplication and rearrangement events, the genes involved in two key pathways producing morphine, codeine, and noscapine have clustered in the genome. Jun 6, 2018 FDA Grants Breakthrough Designation for AutoGenomics' Infiniti Neural Response Panel Dec 14, 2017 Exome Sequencing Links Point Mutation to Family's Insensitivity to Pain Oct 17, 2017 Amgen, Boston Children's Hospital Collaborate to Find Pain Syndrome Genes Sep 28, 2017 Lab Industry Fears Consolidation and Further Price Erosion if PAMA Prices Stick Premium Aug 29, 2017 Prescient Medicine Launches Addiction Risk Test Developed With AutoGenomics Premium Jul 18, 2016 Proove Biosciences Building Opioid PGx Test Evidence; Experts Question Available Data Premium May 6, 2016 Proove Biosciences Acquires Algynomics May 29, 2015 Box Jellyfish Transcriptome, Venom Proteome Reveal Sting Mechanics, Could Inform New Treatments Premium May 26, 2015 Family Sequencing Study Reveals Ties Between Pain Perception, Histone Regulatory Gene Dec 22, 2014 Proove Bio Inks Exclusive Licensing Deal with UNC for Pain Dx Sep 26, 2013 McGill Lands $9.7M for Pain Genetics Chair, Lures US Scientist Oct 18, 2012 Benitec Provides Pipeline Update Following Tacere Acquisition Premium Jun 21, 2012 Benitec Reveals Delays in its Pipeline Programs as Corporate Revitalization Continues Premium Apr 5, 2012 Benitec Aims for Three Clinical Programs, Industry Partnership in 2013 Premium Jan 11, 2012 Genentech Partners with Xenon to Discover, Develop Genetically Targeted Pain Drugs, Companion Tests Premium Jan 11, 2012 Xenon and Genentech Ink Rx, Companion Dx Collaboration and License Pact Nov 3, 2011 Benitec Adds Rare Form of Muscular Dystrophy to Pipeline, Seeks Collaboration for Pain Program Premium Jun 21, 2010 Essen BioScience to Screen Nycomed Drug Candidates Aug 12, 2009 Novartis Evaluating Submission Strategy for Painkiller Prexige in Various Countries Except US Premium Aug 5, 2009 Novartis Using PGx to Resuscitate Previously Failed Pain Drug Prexige with Companion Dx Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.